Eyes may have natural anti-angiogenic response
The vitreous of eyes with retinal or choroidal neovascularisation appear to have higher levels of both pro-angiogenic factors and anti-angiogenic factors compared to eyes without the neovascularisations, according to a new study. The study involved 29 patients from whom vitreous samples were obtained in order to quantify the angiogenesis-associated proteins present via enzyme-linked immunosorbent assays. The researchers found that vitreous levels of the anti-angiogenic VEGF receptor 1 (sVEGFR-1) were significantly higher in eyes with AMD with CNV and in eyes with proliferative diabetic retinopathy than in control eyes. In addition, the concentrations of the anti-angiogenic protein, pigment epithelium-derived factor (PEDF) were decreased and that of proangiogenic angiopoietin 2 were increased. The authors concluded that higher amounts of sVEGFR-1 may point to activation of an endogenous anti-angiogenic system in the protein network.Â
•  (Huber et al Ophthalmologica 2012 (DOI: 10.1159/000339952.) Â
Latest Articles
Simulators Benefit Surgeons and Patients
Helping young surgeons build confidence and expertise.
Making Female Leadership More than a Moment
A remarkable global confluence of women in key positions.
ESCRS Talks Technology at AAO
Europe adopts technological advances, US still waiting for lenses and lasers.
Sorting Out Simultaneous Vision IOLs
The ESCRS Eye Journal Club discuss a new landmark paper on IOL classification and the need for harmonisation of terminology for presbyopic IOLs.
Big Advantages to Small-Aperture IOLs
Small-aperture IOLs offer superior image quality with increased range of focus.
Prioritising Self-Care
Benefits of maintaining physical, emotional, and mental health extend beyond the personal sphere.
Valuing Clinical Trial Design
How inclusivity and diversity can enhance scientific accuracy in research.
Knowing Iris Repair: Using Iridodiathermy in Iris Surgery
Prepare for decentred pupils and uneven irides in multiple situations.
Neuroprotectant Treatment for MacTel Type 2
Intravitreal implant releasing ciliary neurotrophic factor found safe and effective in pivotal trials.